Clinical studies recruiting near Hackensack

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

BioHealx® Anal Fistula Device Post Market Surveillance Study
Phase N/A · Hackensack University Medical Center · Signum Surgical USA Inc. · NCT07021742 KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · John Theurer Cancer Center at Hackensack University Medical · Merck Sharp & Dohme LLC · NCT04165070 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Hackensack University Medical Center · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · John Theurer Cancer Center at Hackensack University Medical · Merck Sharp & Dohme LLC · NCT06136559 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Hackensack University Medical Center · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Hackensack University Medical Center · National Cancer Institute (NCI) · NCT06172296 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · John Theurer Cancer Center at Hackensack University Medical · Bristol-Myers Squibb · NCT07291076 A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Phase 2 · Hackensack Meridian Health (Data Collection Only) · Memorial Sloan Kettering Cancer Center · NCT06594991 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Hackensack University Medical Center, HMH · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Hackensack University Medical Center · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Hackensack University Medical Center · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Hackensack University Medical Center · Giselle Sholler · NCT02559778 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · Hackensack University Medical Center · Clasp Therapeutics, Inc. · NCT06778863 PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Viru
Phase 2 · John Theurer Cancer Center · Pulmotect, Inc. · NCT06665100 The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Phase 2 · Hackensack University Medical Center · Children's Hospital Medical Center, Cincinnati · NCT05538208 Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Hackensack University Medical Center PARTNER · Impact Therapeutics, Inc. · NCT05269316 A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide
Phase 1/Phase 2 · Hackensack University Medical Center · Celgene · NCT06988488 Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Hackensack Meridian Health · University of California, San Francisco · NCT05009992 Selinexor and Backbone Treatments of Multiple Myeloma Patients
Phase 1/Phase 2 · Hackensack University Medical Center - John Theurer Cancer C · Karyopharm Therapeutics Inc · NCT02343042 A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Phase 1 · Hackensack University Medical Center · Boehringer Ingelheim · NCT06882746 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Hackensack University Medical Center · Children's Oncology Group · NCT04322318 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced S
Phase 1/Phase 2 · John Theurer Cancer Center · ModernaTX, Inc. · NCT05533697 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · John Theurer Cancer Center at Hackensack University Medical · Merck Sharp & Dohme LLC · NCT06077760 Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
Phase 1/Phase 2 · Laminar Pharmaceuticals · NCT04299191 A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select
Phase 1 · John Theurer Cancer Center at Hackensack University Medical · Bristol-Myers Squibb · NCT06476808 OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression
NA · Hackensack University Medical Center · Hackensack Meridian Health · NCT06991166 Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Phase 2 · Hackensack Meridian Health · Memorial Sloan Kettering Cancer Center · NCT04410796 Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Phase 2 · Joseph M. Sanzari Children's Hospital at Hackensack Universi · University of California, San Francisco · NCT07110246 AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Phase N/A · Hackensack University Medical Center · Peerbridge Health, Inc · NCT06699056 Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · Regional Cancer Care Associates · Schrödinger, Inc. · NCT05544019

Look up another city

Look up another condition